Observational study on Vitamin C Injektopas® for vitamin C deficiency
Observational Study on Vitamin C-Injektopas® 7.5g in Patients With Vitamin C Deficiency Due to Acute and Chronic Diseases
This study is testing how well Vitamin C Injektopas® helps people with vitamin C deficiency feel better over time and if they can handle the treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | Pascoe Pharmazeutische Praeparate GmbH Industry-sponsored |
| Locations | 1 site (Vienna, Etc., Austria) |
| Trial ID | NCT06983847 on ClinicalTrials.gov |
What this trial studies
This observational study aims to document the use of Vitamin C Injektopas® 7.5g in patients diagnosed with vitamin C deficiency, either through laboratory tests or clinical symptoms. It will assess how symptoms related to vitamin C deficiency change over time and evaluate the tolerability of the treatment. The study will include patients with both acute and chronic diseases that lead to vitamin C deficiency, focusing on various symptoms such as fatigue, susceptibility to infections, and issues related to collagen formation. The overall efficacy and tolerability of the therapy will also be evaluated through patient surveys.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with vitamin C deficiency.
Not a fit: Patients with hypersensitivity to the active ingredient, renal insufficiency, or certain blood disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management of vitamin C deficiency and its associated symptoms in patients.
How similar studies have performed: While observational studies on vitamin C deficiency exist, this specific approach using Vitamin C Injektopas® is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with vitamin C deficiency * Age ≥ 18 years Exclusion Criteria: * Hypersensitivity to the active ingredient or any of the excipients * Oxalate urolithiasis * Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion * Renal insufficiency * Glucose-6-phosphate dehydrogenase deficiency/defect * Pregnant/breastfeeding women
Where this trial is running
Vienna, Etc., Austria
- Multiple Physicians from Austria — Vienna, Etc., Austria, Austria (Recruiting)
Study contacts
- Study coordinator: Jennifer Brueckmann, CRA
- Email: jennifer.brueckmann@pascoe.de
- Phone: 00496417960955
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.